Abstract
The protein kinase C (PKC) signaling pathwayplays a key role in tumor cell proliferation,differentiation, and apoptosis. Gastric cancer usuallypossesses a higher level of PKC activity than normaltissue. We evaluated inhibition of PKC activity inapoptosis induction of gastric cancer cells and theexpression profile of apoptosis-related genes. Gastriccancer cells (AGS) were incubated with two highlyspecific PKC inhibitors (RO-31-8220 and chelerythrine).Cell viability and cell cycle were determined bymethyl-tetrazolium (MTT) assay and flow cytometry,respectively. Apoptosis was characterized by acridineorange staining, DNA gel electrophoresis, and flowcytometry. The expression of p53,p21waf/cip1, c-myc, bcl-2, and bax wasdetermined by western blot. The results showed that bothPKC inhibitors hindered cell growth, arrested cells atG0/G1 phase and induced apoptosis.The protein level of p53, p21waf/cip1, c-myc,and bax was elevated while bcl-2 kept unchangedfollowing drug exposure. In conclusion, PKC inhibitorssuppress growth of gastric cancer cells throughapoptosis induction and cell cycle quiescence, which maybe regulated by differential expression ofapoptosis-related genes.
Similar content being viewed by others
REFERENCES
Kizaki H, Ohnishi Y, Mizuno Y, Azuma Y, Mizuno Y, Ohsaka F: Arabinolcytosine and 5'-azacytisine induce internucleosomal DNA fragmentation and cell death in thymocytes. Immunopharmacology 24:219–227, 1992
Lin YH, Priebe W, Peterz-Soler R: Apoptosis induced by anthracyclne antibiotics in P3888 parent and multidrug resistance cells. Cancer Res 53:1845–1852, 1993
Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, Wyllie AH: Thymocyte apoptosis induced by p53–dependent and independent pathways. Nature 362:849–852, 1993
Askew DS, Ashmun RA, Simmons BC, Cleveland JL: Constitutive c-myc expression in an IL-3 dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 6:1915–1922, 1991
Hale AJ, Smith CA, Sutherland LC, Stoneman VEA, Longthorne VL, Culhane AC, Williams GT: Apoptosis: Molecular regulation of cell death. Eur J Biochem 236:1–26, 1996
Clemens MJ, Trayner I, Menay J: The role of protein kinase C isoenzymes in the regulation of cell proliferation and differentiation. J Cell Sci 103:881–887, 1992
Lucas M, Margalet VS: Protein kinase C involvement in apoptosis. Gen Pharmacol 26:881–887, 1995
Yasui W, Sumiyoshi H, Ochiai A, Tahara E: Calciumactivated, phospholipid-dependent protein kinase in human mucosa and carcinoma. Jpn J Cancer Res 76:1168–1173, 1985
Schwartz GK, Jiang J, Kelsen D, Albino AP: Prote in kinase C: A novel target for inhibiting gastric cancer cell invasion. J Natl Cancer Inst 85:402–407, 1993
Carmichae l J, Mitchell JB, DeGraff WG, Gamson J, Gazder AF, Johnson BE, Glatstein E, Minna JD: Chemosensitivity testing of human lung cancer cell lines using the MTT assay. Br J Cancer 57:540–547, 1985
Elder DJE, Hague A, Hicks DJ, Paraskeva C: Differential growth inhibition by the aspirin metabolite salicylate in human colorectal tumor cell lines: Enhanced apoptosis in carcinoma and in vitro-transformed adenomare lative to adenoma cell lines. Cancer Res 56:2273–2276, 1996
Grant S, Jarvis WD, Swerdlow PS, Turner AJ, Traylor RS, Wallace HJ, Lin PS, Pettit GR, Gewirtz DA: Potentiation of the activity of 1–ß-D-arabinofuranosylcytosine by the protein kinase C activator bryostatin 1 in HL-60 cells: Association with enhanced fragme ntation of mature DNA. Cancer Res 52:6270–6278, 1992
Darzynkiewicz Z, Bruno S, del Bino S, Gorczyca W, Hotz MA, Lassota P, Traganos F: Features of apoptotic cells by flow cytometry. Cytometry 13:795–808, 1992
Li Y, Davis KL, Sytkowski AJ: Protein kinase C-e is necessary for erythropoietin's upregulation of c-myc and for factorsdependent DNA synthesis. J Biol Chem 271:27025–27030,1996
Hofmann J: The potential for isoenzyme-selective modulation of protein kinase C. FASEB J 11:649–669, 1997
Zhang HC, Hoang T, Saeed B, Ng SC: Induction of apoptosis in prostatic tumor cell line DU145 by staurosporine, a potent inhibitor of protein kinases. Prostate 29:69–76, 1996
Ikemoto H, Tani E, Matsumoto T, Nakano A, Furuyama JI: Apoptosis of human glioma cells in response to calphostin C, a specific protein kinase C inhibitor. J Neurosurg 83:1008–1016,1995
Jarvis WD, Turner AJ, Povirk LF, Traylor RS, Grant S: Induction of apoptotic DNA fragmentation and cell death in HL-60 human promye locytic leukemia cells by pharmacological inhibitors of protein kinase C. Cancer Res 54:1707–1714, 1994
Zhu GH, Wong BCY, Eggo MC, Ching CK, Yuen ST, Chan EYT, Lai KC, Lam SK: Nonsteroidal antiinflammatory druginduced apoptosis in gastric cancer cells is blocked by protein kinase C activation through inhibition of c-myc. Br J Cancer 79:393–400, 1999
Mercep M, Noguchi PD, Ashwell JD: The cell cycle block and lysis of an activated T cell hybridoma are distinct processes with different Ca2+ requirements and sensitivity to cyclosporine A. J Immunol 142:4085–4092, 1989
Ojeda F, Guarda MI, Maldonado C, Folch H: Protein kinase-C involveme nt in thymocyte apoptosis induced by hydrocortisone. Cell Immunol 125:535–539, 1990
Schwartz GK, Haimovitz Friedman A, Dhupar SK, Ehleiter D, Maslak P, Lai L, Loganzo F Jr, Ke lsen DP, Fuks Z, Albino AP: Potentiation of apoptosis by treatment with the protein kinase C-specific inhibitor safingol in mitomycin C-treated gastric cancer cells. J Natl Cance r Inst 87:1394–1399, 1995
Courage C, Snowden R, Gescher A: Differential effects of staurosporine analogues on cell cycle, growth and viability in A549 cells. Br J Cancer 74:1199–1205, 1996
Thompson LJ, Fields AP: b II protein kinase C is required for the G2/M phase transition of cell cycle. J Biol Chem 271:15045–15053, 1996
Liebermann DA, Hoffman B, Steinman RA: Molecular controls of growth and apoptosis: p53–dependent and independent pathways. Oncogene 11:199–210, 1995
Harrington E, Fanidi A, Bennett M, Evan G: Modulation of Myc-induced apoptosis by specific cytokines. EMBO J 13:3286–3295, 1994
Fanidi A, Harrington EA, Evan GI: Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature 359:554–556, 1992
Xu G, Gai Q, James CB: Protein kinase C inhibits transcription from the RNA polymerase III promoter of the human c-mycgene. Cancer Lett 123:199–205, 1998
Newton K, Strasser A. The Bcl-2 family and cell death regulation. Curr Opin Genet Dev 8:68–75, 1998
Reed JC: Bcl-2 and the regulation of programmed cell death. J Cell Biol 124:1–6, 1994
McDonnell TJ, Beham A, Sarkiss M, Andersen MM, Lo P: Importance of the Bcl-2 family in cell death regulation. Experientia 52:1008–1017, 1996
Itano Y, Ito A, Uehara T, Nomura Y: Regulation of Bcl-2 protein expression in human neuroblastoma SH-SY5Y cells: positive and negative effects of protein kinases C and A, respectively. J Neurochem 67:131–137, 1996
Shen L, Glazer RI: Induction of apoptosis in glioblastoma cells by inhibition of protein kinase C and its association with the rapid accumulation of p53 and induction of the insulin-like growth factor-1–binding prote in-3. Biochem Pharmacol 55:1711–1719, 1998
Rights and permissions
About this article
Cite this article
Zhu, G.H., Wong, B.C.Y., Eggo, M.C. et al. Pharmacological Inhibition of Protein Kinase C Activity Could Induce Apoptosis in Gastric Cancer Cells by Differential Regulation of Apoptosis-Related Genes. Dig Dis Sci 44, 2020–2026 (1999). https://doi.org/10.1023/A:1026670301787
Issue Date:
DOI: https://doi.org/10.1023/A:1026670301787